S. A. Papoyan

S. A. Papoyan

Auto-generated profile, based on publicly available information

S. A. Papoyan

City Clinical Hospital named after F.I. Inozemtsev, Moscow

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2023 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
OSO. A. Slyusareva
O. A. Slyusareva
AMA. E. Markarov
A. E. Markarov
SAS. V. Apresyan
S. V. Apresyan
JDJ. E. Dobrokhotova
J. E. Dobrokhotova
SKS. A. Khlynova
S. A. Khlynova
EME. A. Markova
E. A. Markova
Introduction. The efficacy of preoperative therapy with Gynestril in the treatment of symptomatic uterine fibroids and anaemia of various degrees of severity was studied in the prospective, comparative cohort study.Aim. To evaluate the efficacy of preoperative therapy with mifepristone in patients with uterine fibroids and chronic iron deficiency anaemia of various degrees of severity.Materials and methods. The study included 70 women who were scheduled to undergo the organ-preserving surgical treatment due to symptomatic uterine fibroids from January 1, 2017 to December 31, 2022. 50 patients received Gynestril at a dose of 50 mg/day (1 tablet) from day 1 of the menstrual cycle for 3 consecutive months. Due to contraindications to its use, 20 patients refused to administer the drug in the preoperative period and received symptomatic haemostatic therapy, and were included in the control groups. The patients of both groups received anti-anaemic therapy with iron(III)-hydroxide polymaltose tablets, 250– 300 mg/ day orally. 40 patients underwent the organ-preserving surgery depending on the size, number, type and localization of uterine fibroids according to the FIGO 2011 classification and patients’ motivation to preserve their reproductive function.Results. The analysis of changes in the laboratory test results revealed that hemoglobin levels in the groups after Gynestril therapy reached reference ranges in all women, averaging 123.4 ± 8.2 g/l as compared to the baseline value 84.3 ± 6.7 g/l, p < 0.05. It was also noted that ferritin levels increased significantly, averaging 12.2 ± 1.9 µg/l compared to the pre-treatment level 8.8 ± 0.8 µg/l, serum iron levels reached 12.8 ± 1.0 compared to the pre-treatment level 8.0 ± 0.8, and TIBC level reduced to 72.1 ± 3.5 compared to the pre-treatment level 96.7 ± 4.8 (p < 0.05).Conclusions. A comprehensive multidisciplinary approach to the treatment of uterine fibroids, including preoperative therapy with Gynestril, myomectomy using occlusive and X-ray endovascular techniques preserved the reproductive function in 50 patients with symptomatic uterine fibroids and anaemia of various degrees of severity.

27 January 2024 in Russian journal of neurosurgery
Verified
Journal Article
Open access
PDF file
AAA. A. Ayrapetyan
A. A. Ayrapetyan
DGD. G. Gromov
D. G. Gromov
SPS. A. Papoyan
S. A. Papoyan
DSD. V. Smyalovskiy
D. V. Smyalovskiy
KAK. S. Asaturyan
K. S. Asaturyan
ETE. V. Tavlueva
E. V. Tavlueva
Traumatic vertebral artery injury (TVAI) is a rare but severe pathology which can be associated both with penetrating injury of the neck and blunt or unclassified injury. Injury of the vertebral artery, especially due to gunshot or knife wounds, causes severe condition of the patients, development of a wide spectrum of complications including life-threatening, high rates of disabilities and mortality.There is no consensus on the treatment tactics for this pathology. Open surgery as the first stage of surgical intervention can be used in a limited number of cases. X-ray endovascular techniques of TVAI treatment are considered to be preferable.We present a clinical case of a 27‑year-old patient with TVAI caused by a penetrating gunshot wound of the neck and complicated by formation of a giant pseudoaneurysm of the V3 segment of the vertebral artery. Two-stage combination treatment of TVAI was performed using endovascular and open surgical techniques.Descriptions of TVAI cases are rare, and further accumulation and analysis of corresponding data and proposals on treatment of the patients with TVAI will help to formulate precise algorithms of doctors’ actions and optimize treatment tactics.

1 January 2023 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
ASA.A. Shchegolev
A.A. Shchegolev
SPS.A. Papoyan
S.A. Papoyan
MMM.M. Mutaev
M.M. Mutaev
DSD.D. Syromyatnikov
D.D. Syromyatnikov
DKD.S. Komarova
D.S. Komarova
Проблема лечения многоуровневого атеросклеротического поражения артериального русла нижних конечностей стоит в современной медицине очень остро. Единого алгоритма лечения на настоящий момент не выработано. Одним из возможных способов ее решения является использование гибридных технологий. Существуют обоснованные предположения, что использование этих технологий позволит если не полностью, то хотя бы частично решить эту проблему. Несомненным достоинством гибридных технологий является их малая травматичность. Поэтому их использование позволит осуществлять лечение тяжелых пациентов с различными сопутствующими заболеваниями, которым невозможно помочь традиционными методами. Таким образом, изучение гибридного метода представляет большой интерес для сердечно-сосудистых хирургов. Гибридный метод сейчас признан одним из самых эффективных и малотравматичных видов лечения пациентов с атеросклеротическим поражением нижних конечностей.

7 October 2022 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
AMA. E. Markarov
A. E. Markarov
JDJu. E. Dobrokhotova
Ju. E. Dobrokhotova
SKS. A. Khlynova
S. A. Khlynova
VDV. I. Dimitrova
V. I. Dimitrova
SPS. A. Papoyan
S. A. Papoyan
SAS. S. Apresyan
S. S. Apresyan
   Introduction. The necessity to improve methods of adenomyosis treatment is determined not only by its high prevalence, which reaches 40 % among women of reproductive age, but also by its association with infertility of unclear genesis. The disease significantly reduces the quality of life.   Objective. To optimize reproductive outcomes after surgical treatment of nodular adenomyosis and to prevent the disease recurrence.   Materials and Methods. A cohort prospective comparative study examined the efficacy of therapy with dienogestam after laparoscopic removal of adenomyosis nodules with temporary uterine artery occlusion and temporary balloon occlusion of the internal iliac arteries. The study included 25 women who underwent organ-preserving treatment for nodular adenomyosis from January 1, 2020 to January 1, 2022. Inclusion criteria: age 22–45 years, mean 32 ± 4.5; organ preserving treatment for nodular adenomyosis, no contraindications to hormone therapy, informed voluntary consent of the patient to participate in the study.   Results. The use of Dientogest at a dose of 2 mg/day in a continuous regimen for 6 months after surgical treatment for nodular adenomyosis was shown to transform the intensity of pain syndrome to insignificant, the absence of recurrent disease for 24 months of follow-up.   Conclusions. The comprehensive treatment of nodular adenomyosis, which included laparoscopic removal of the nodule and the drug therapy with dienogestam, permitted the achievement of reproductive function in 40% of the patients. The choice of the treatment method for nodular adenomyosis depends primarily on the reproductive plans of the patient, the size and location of the adenomyosis nodules, and its long-term results depend on the comprehensive antiretroviral therapy.

11 May 2024 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
JDJu. E. Dobrokhotova
Ju. E. Dobrokhotova
AMA. E. Markarov
A. E. Markarov
MPM. A. Ponimanskaya
M. A. Ponimanskaya
SAS. V. Apresyan
S. V. Apresyan
SKS. A. Khlynova
S. A. Khlynova
OSO. A. Slyusareva
O. A. Slyusareva
Introduction. Uterine fibroids are ranked second and endometriosis is ranked third in the gynaecological pathology pattern. Uterine fibroids and endometriosis are among the most common diseases of the female genitalia and occur in every 4–5 gynaecological patients.Aim. To improve a multidisciplinary approach to the choice of surgical organ-preserving treatment strategies in hyperplastic diseases of the uterus using occlusion techniques.Materials and methods. A cohort prospective comparative study examined a multidisciplinary approach to the choice of surgical organ-preserving treatment strategies in uterine hyperplastic hysteropathies using occlusion techniques.Results. The study showed that uterine artery embolization is indicated if FIGO 2–5 fibroids’ size is > 4 cm in patients who are not planning pregnancy. The laparoscopic myomectomy with temporary uterine artery occlusion is provided if FIGO 2–6 fibroids’ size is from 6.0 to 8.0 cm, the laparoscopic myomectomy with temporary balloon occlusion of the internal iliac arteries is the procedure of choice if fibroids’ size is from 8.0 to 12.0 cm and they are located in the cervical-isthmus region and in areas of vascular bundles, and vaginal myomectomy with temporary balloon occlusion of the common iliac arteries is performed if FIGO 8 fibroids’ size is > 4 cm and they are located in the cervix. If adenomyosis nodes’ size is from 4.0 to 6.0 cm, they are removed using laparoscopic access with temporary occlusion of the uterine arteries; if adenomyosis nodes’ size is ≥ 6.0 cm, they are removed using laparoscopic access with temporary balloon occlusion of the internal iliac arteries.Conclusion. The multidisciplinary approach in the treatment of hyperplastic diseases of the uterus is regarded as optimal.

20 October 2023 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
SAS. V. Apresyan
S. V. Apresyan
AMA. E. Markarov
A. E. Markarov
JDJu. E. Dobrokhotova
Ju. E. Dobrokhotova
SKS. A. Khlynova
S. A. Khlynova
VDV. I. Dimitrova
V. I. Dimitrova
OSO. A. Slyusareva
O. A. Slyusareva
Introduction. The relevance of studying the mechanisms underlying the development of adenomyosis is determined not only by its high prevalence reaching 40% among reproductive aged women, but also by its association with unexplained infertility (60%), as well as woman’s quality of life impairment.Aim. To enhance efficiency of therapy after surgical treatment of endometriosis and minimize the risk of disease recurrence.Materials and methods. In a cohort prospective comparative study conducted on the basis of the gynecological department of the Inozemtsev City Clinical Hospital, 80 patients of reproductive age who underwent organ-preserving treatment for external genital endometriosis and nodular adenomyosis were included. Dienogest (Zafrilla) was prescribed to 65 patients at a dose of 2 mg/day (1 tablet) from day 2 after surgical treatment continuously for 6 months, taking into account contraindications to its use, 15 patients refused to take the drug in the postoperative period, and made up the control group.Results. The results of the study showed that after surgical treatment of external genital endometriosis and the nodular form of adenomyosis and the appointment of suppressive therapy with Zafrilla, after 3 months, the intensity of the pain syndrome was transformed according to the VAS, NRS, B&B scales by one step, and after 6 months it decreased to a slight (p < 0.05), which contributed to the improvement of the quality of life of patients based on the EHP-30 questionnaire. The long-term results of the study allow us to recommend the drug Zafrilla, with high compliance, good tolerance, a favorable safety profile, in order to reduce pain, the intensity of menstrual flow, and prevent recurrence of the disease based on 24 months of observation.Conclusion. An integrated approach to the treatment of external genital endometriosis and nodular adenomyosis, including surgical treatment and suppressive therapy with Zafrilla, made it possible to realize reproductive function in 48% of patients. Taking dienogest for 24 weeks provided effective relief of pain, alleviated the symptoms of the disease, as well as improved the quality of life and realized reproductive plans.